Connect with us


Novavax Nears Covid-19 Vaccine Game Changer—After Years of Failure – The Wall Street Journal

If authorized, its shot could be one of the more powerful weapons against the pandemic



Article feature image

In January of last year, employees of Novavax Inc. met at a local Maryland bar to discuss how they might salvage their careers. For decades, the small biotech had tried to develop an approved vaccine, with no success. The company had enough cash to survive only another six months or so and its shares traded under $4, with a market value of $127 million.
Today, Novavax is advancing toward authorization of a Covid-19 vaccine. Scientists believe that, if cleared, it could be one of the more powerful…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Sutter to cancel up to 95,000 vaccine appointments in Northern California – SF Gate
Article feature image
Zoom Video Communications Stock Slides. Here’s What Is Worrying Investors. – Barron’s
Article feature image
Microsoft issues emergency patches for 4 exploited 0-days in Exchange – Ars Technica